Cancer 
        Digest        

CANCER DIGEST – Feb. 11, 2023 – Non-small cell lung cancer patients given a new targeted therapy experienced longer disease-free survival and lower risk of recurrence compared to patients not given the drug, according to preliminary data from an ongoing clinical trial.

Read more ...